Endometriosis. Endometriosis
Conditions
Interventions
Intervention 1: Intervention group: The intervention group will include 33 patients with endometrial polyps who will receive 20 mg of dydrogesterone daily (10 mg Duphaston® tablet manufactured by ABBO
importer: Behestan Darou Company, twice a day) from day 15 to 24 of the menstrual cycle for 3 months. Intervention 2: Control group: There will be 33 patients with endometrial polyps who will receive
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
19 Years to 49 Years
Inclusion criteria
Inclusion criteria: Full consent to participate in this study Premenstrual women (age between 20 and 50 years) Having one of the following symptoms in transvaginal ultrasound within 10 days after the start of the menstrual period: Typical symptoms of endometrial polyps: Medium to high echo with a regular margin in the uterine cavity b- atypical symptoms of endometrial polyps: Penetrating cyst in endometrial tissue No history of allergy to hormonal drugs intermenstural bleeding Menorrhagia (more than 2 times compared to the normal state)
Exclusion criteria
Exclusion criteria: History of taking progesterone supplements or hormonal medications in the past 6 months Contraindications to the use of progesterones History of surgery or treatment for endometrial lesions in the past 6 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Size, polyp size, and endometrial thickness. Timepoint: Endometrial polyp changes will be evaluated before and 3 months after the intervention. Method of measurement: The size, shape, and thickness of the endometrium will be assessed based on ultrasound findings. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactEnsie Rezaee
Shahid Beheshti University of Medical Sciences
Outcome results
None listed